Entrada Therapeutics, Inc. (TRDA)
5.69
-0.20
(-3.40%)
USD |
NASDAQ |
May 19, 15:55
Entrada Therapeutics EPS Diluted (TTM) : -3.998 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 16.87 |
| Tyra Biosciences, Inc. | -2.174 |
| Biogen, Inc. | 9.318 |
| Catalyst Pharmaceuticals, Inc. | 1.740 |
| XOMA Royalty Corp. | 1.571 |